All Comments by

  1. Elizabeth Head on Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism.
  2. Lary Walker on Participation in dementia research: rates and correlates of capacity to give informed consent.
  3. Michael G. Agadjanyan on A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta.
  4. Akihiko Nunomura on Immunotherapy: Old Dogs, New Tricks
  5. Elizabeth Head on A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta.
  6. Davide Tampellini on Keystone Drug News: Glimpse of Lilly’s Phase 1 Passive Vaccine
  7. Anusuyadevi Jayachandran on Persistence of (Worm) Memory Depends on Calsyntenin/Alcadein Ortholog
  8. Tommaso Russo on Neurogenesis Gets a Jolt From Enhanced APP Processing, Curcumin
  9. Ralph Nixon on Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.
  10. Brigita Urbanc on Affibodies—Putting the β in Aβ?
  11. Kumar Sambamurti on Keystone Drug News: CoMentis BACE Inhibitor Debuts
  12. Dave Morgan on A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta.
  13. Gregory Cole on Neurogenesis Gets a Jolt From Enhanced APP Processing, Curcumin
  14. Mike Malek-Ahmadi on Alzheimer Activism: How To Modernize Clinical Trials?
  15. Virgil Muresan on New Role for p25/Cdk5 in Regulation of BACE Expression